Eam Investors, LLC Cytosorbents Corp Transaction History

Eam Investors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$7.37 - $11.54 $1.21 Million - $1.9 Million	-164,400 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$6.28 - $10.59 $177,736 - $299,718	28,302 Added 20.8%	164,400 $1.63 Million
Q1 2020 May 13, 2020	BUY	$3.77 - $7.73 $513,089 - $1.05 Million	136,098 New	136,098 $1.05 Million
Q1 2019 May 13, 2019	SELL	$6.82 - $8.56 $733,361 - $920,465	-107,531 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$7.05 - $12.64 $279,553 - $501,213	-39,653 Reduced 26.94%	107,531 $869,000
Q3 2018 Nov 08, 2018	SELL	$10.95 - $14.8 $344,990 - $466,288	-31,506 Reduced 17.63%	147,184 $1.9 Million
Q2 2018 Aug 03, 2018	BUY	$6.9 - $12.35 $639,788 - $1.15 Million	92,723 Added 107.86%	178,690 $2.04 Million
Q1 2018 May 14, 2018	BUY	$6.55 - $8.2 $563,083 - $704,929	85,967 New	85,967 $606,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.